Politics April 21, 2026 02:35 PM

Kennedy Says White House Did Not Tell Him to Stop Discussing Vaccines Before Midterms

Health Secretary reiterates independence on vaccine messaging during fourth congressional hearing this week

By Maya Rios
Kennedy Says White House Did Not Tell Him to Stop Discussing Vaccines Before Midterms

Health Secretary Robert F. Kennedy Jr. told members of Congress on Tuesday that no one in the White House instructed him to halt public discussion of vaccines or other contentious positions ahead of November’s midterm elections. Speaking at his fourth hearing of the week, Kennedy emphasized nutrition and food safety in his prepared remarks, and denied being directed by senior White House staff to avoid vaccine-related topics. A White House ally and food policy adviser echoed that denial at a healthcare summit in Washington.

Key Points

  • Kennedy told Congress he was not instructed by the White House to stop discussing vaccines ahead of the midterm elections - impacts public health and political communications.
  • In his fourth hearing this week, Kennedy focused on nutrition and food safety and did not raise his recent vaccine-policy initiatives or autism-related work - relevant for CDC oversight and health policy markets.
  • A White House food policy adviser, Calley Means, echoed Kennedy's denial at the Politico Health Care Summit, framing the exchange as a matter of prioritization within American healthcare messaging - relevant to political strategy and public health stakeholders.

Health Secretary Robert F. Kennedy Jr. told lawmakers on Tuesday that the White House did not direct him to stop discussing vaccines or other contentious policy positions in the run-up to November’s midterm elections.

At his fourth Congressional hearing this week, Kennedy opened by stressing issues related to nutrition and food safety. In that opening statement he omitted mention of his recent efforts to change national vaccination policy or his work to probe causes of autism.

During questioning Representative Marc Veasey, a Democrat from Texas, asked Kennedy whether White House Chief of Staff Susie Wiles or any other official had instructed him to refrain from raising vaccine skepticism. Kennedy replied succinctly: "no."

An earlier news report this month said the White House had asked health officials to shift policy conversations toward topics perceived as more popular, as President Donald Trump and the Republican Party aim to hold narrow congressional majorities. Kennedy’s response to Veasey directly addressed those reporting lines by denying any such instruction.

Kennedy, who has been identified publicly as a longstanding anti-vaccine activist, experienced a legal setback last month when a court blocked significant parts of his proposed revisions to U.S. vaccine policy and his plan to overhaul a CDC advisory panel on immunizations.

Calley Means, a White House food policy adviser and described in coverage as a close ally of Kennedy, also rejected the notion that the administration told Kennedy and his associates to avoid discussing vaccines. Speaking at the Politico Health Care Summit in Washington, Means said: "I think that these are just ongoing conversations about where to prioritize on what’s leading to a problem in American healthcare." She added, "We’re not apologizing for what’s happened on vaccines."

Separately on Tuesday, Kennedy said he had reviewed Erica Schwartz’s stance on vaccines prior to her nomination to lead the U.S. Centers for Disease Control and Prevention. Kennedy’s remarks came amid heightened scrutiny of vaccination policy debates and public health messaging as political actors consider messaging priorities ahead of the midterm elections.


Context and reporting limits - The statements in this article are drawn from testimony and public comments made during the week of hearings and the Politico Health Care Summit. Where reporting cited earlier coverage that the White House had urged a shift in discussion topics, Kennedy and a close ally denied receiving or acting on any directive to stop discussing vaccines. The article does not add or infer additional motives or outcomes beyond those stated publicly by the involved parties.

Risks

  • Ongoing public debate and legal challenges around vaccine policy may sustain policy uncertainty - affects public health agencies and related healthcare sectors.
  • Conflicting public statements and media reports about internal White House communications could increase political risk ahead of the midterms - affects political risk assessments for sectors sensitive to regulatory and reputational shifts, including healthcare and pharmaceuticals.

More from Politics

Civil rights groups sue to block DOJ access to state voter rolls, citing risk of unlawful purges Apr 21, 2026 Public Confidence in Trump’s Temperament Falters as Iran Conflict and Pope Feud Intensify Apr 21, 2026 Virginia Voters Decide on Democratic Map That Could Reclaim Four GOP House Seats Apr 21, 2026 Supreme Court to Review Colorado Preschool Funding Rule After Challenge from Archdiocese of Denver Apr 20, 2026 Appeals Court Temporarily Allows Construction of $400 Million White House Ballroom Apr 20, 2026